Susan Zolla-Pazner

Susan Zolla-Pazner is an American research scientist who is a Professor of Medicine in the Division of Infectious Diseases and the Department of Microbiology at Mount Sinai School of Medicine and a guest investigator in the Laboratory of Molecular Immunology at The Rockefeller University, both in New York City. Zolla-Pazner's work has focused on how the immune system responds to the human immunodeficiency virus (HIV) and, in particular, how antibodies against the viral envelope develop in the course of infection.
In 1981, Zolla-Pazner and other researchers initially described the immunologic abnormalities afflicting homosexual men in New York City who were dying from an unknown sickness. In the years since, she has examined the body's immune response to the virus. She is the co-inventor on 23 patents and the author of more than 325 scientific publications. Provided by Wikipedia
Showing 1 - 20 results of 33 for search 'Susan Zolla-Pazner', query time: 0.08s
Refine Results
-
1
Immunoprophylaxis against mother-to-child transmission of HIV-1. by Miroslaw K Gorny, Susan Zolla-Pazner
Published 2006-07-01
Article -
2
-
3
-
4
-
5
Resistance of Subtype C HIV-1 Strains to Anti-V3 Loop Antibodies by David Almond, Chavdar Krachmarov, James Swetnam, Susan Zolla-Pazner, Timothy Cardozo
Published 2012-01-01
Article -
6
-
7
-
8
-
9
The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time. by Alisa Fox, Jessica Marino, Fatima Amanat, Kasopefoluwa Y Oguntuyo, Jennifer Hahn-Holbrook, Benhur Lee, Susan Zolla-Pazner, Rebecca L Powell
Published 2022-01-01
Article -
10
Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. by Ekaterina Dadachova, Mahesh C Patel, Sima Toussi, Christos Apostolidis, Alfred Morgenstern, Martin W Brechbiel, Miroslaw K Gorny, Susan Zolla-Pazner, Arturo Casadevall, Harris Goldstein
Published 2006-11-01
Article -
11
Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradication. by Ekaterina Dadachova, Scott G Kitchen, Gregory Bristol, Gayle Cocita Baldwin, Ekaterina Revskaya, Cyril Empig, George B Thornton, Miroslaw K Gorny, Susan Zolla-Pazner, Arturo Casadevall
Published 2012-01-01
Article -
12
Correction: Pre-Clinical Evaluation of a Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication. by Ekaterina Dadachova, Scott G. Kitchen, Gregory Bristol, Gayle Cocita Baldwin, Ekaterina Revskaya, Cyril Empig, George B. Thornton, Miroslaw K. Gorny, Susan Zolla-Pazner, Arturo Casadevall
Published 2012-01-01
Article -
13
Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subject. by Liuzhe Li, Xiao-Hong Wang, Sagarika Banerjee, Barbara Volsky, Constance Williams, Diana Virland, Arthur Nadas, Michael S Seaman, Xuemin Chen, Paul Spearman, Susan Zolla-Pazner, Miroslaw K Gorny
Published 2012-01-01
Article -
14
Combination of anti-retroviral drugs and radioimmunotherapy specifically kills infected cells from HIV infected individuals by Dina Tsukrov, Alicia McFarren, Alfred Morgenstern, Frank Bruchertseifer, Eugene Dolce, Miroslaw K Gorny, Susan Zolla-Pazner, Joan W Berman, Ellie Schoenbaum, Barry S Zingman, Arturo Casadevall, Ekaterina Dadachova
Published 2016-09-01
Article -
15
Signal peptide of HIV-1 envelope modulates glycosylation impacting exposure of V1V2 and other epitopes. by Chitra Upadhyay, Roya Feyznezhad, Liwei Cao, Kun-Wei Chan, Kevin Liu, Weiming Yang, Hui Zhang, Jason Yolitz, James Arthos, Arthur Nadas, Xiang-Peng Kong, Susan Zolla-Pazner, Catarina E Hioe
Published 2020-12-01
Article -
16
Human anti-V3 HIV-1 monoclonal antibodies encoded by the VH5-51/VL lambda genes define a conserved antigenic structure. by Miroslaw K Gorny, Jared Sampson, Huiguang Li, Xunqing Jiang, Maxim Totrov, Xiao-Hong Wang, Constance Williams, Timothy O'Neal, Barbara Volsky, Liuzhe Li, Timothy Cardozo, Phillipe Nyambi, Susan Zolla-Pazner, Xiang-Peng Kong
Published 2011-01-01
Article -
17
Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor. by Kristina K Peachman, Nicos Karasavvas, Agnes-Laurence Chenine, Robert McLinden, Supachai Rerks-Ngarm, Kaewkungwal Jaranit, Sorachai Nitayaphan, Punnee Pitisuttithum, Sodsai Tovanabutra, Susan Zolla-Pazner, Nelson L Michael, Jerome H Kim, Carl R Alving, Mangala Rao
Published 2015-01-01
Article -
18
Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patients by Jéromine Klingler, Gregory S. Lambert, Juan C. Bandres, Rozita Emami-Gorizi, Arthur Nádas, Kasopefoluwa Y. Oguntuyo, Fatima Amanat, Maria C. Bermúdez-González, Charles Gleason, Giulio Kleiner, Viviana Simon, Benhur Lee, Susan Zolla-Pazner, Chitra Upadhyay, Catarina E. Hioe
Published 2022-12-01
Article -
19
Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces by Myungjin Lee, Anita Changela, Jason Gorman, Reda Rawi, Tatsiana Bylund, Cara W. Chao, Bob C. Lin, Mark K. Louder, Adam S. Olia, Baoshan Zhang, Nicole A. Doria-Rose, Susan Zolla-Pazner, Lawrence Shapiro, Gwo-Yu Chuang, Peter D. Kwong
Published 2021-11-01
Article -
20
A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses by Xiaoying Shen, Bette Korber, Rachel L. Spreng, Sheetal S. Sawant, Allan deCamp, Arthur S. McMillan, Ryan Mathura, Susan Zolla-Pazner, Abraham Pinter, Robert Parks, Cindy Bowman, Laura Sutherland, Richard Scearce, Nicole L. Yates, David C. Montefiori, Barton F. Haynes, Georgia D. Tomaras
Published 2025-01-01
Article